Cargando…
Anti-GD2 Directed Immunotherapy for High-Risk and Metastatic Neuroblastoma
Neuroblastoma is one of the few childhood cancers that carries a tumor-specific antigen in the form of a glycolipid antigen known as GD2. It has restricted expression in normal tissue, such as peripheral afferent nerves. Monoclonal antibodies targeting GD2 have been applied clinically to high-risk n...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945428/ https://www.ncbi.nlm.nih.gov/pubmed/35327550 http://dx.doi.org/10.3390/biom12030358 |